Logo image of LEG.DE

LEG IMMOBILIEN SE (LEG.DE) Stock Fundamental Analysis

FRA:LEG - Deutsche Boerse Ag - DE000LEG1110 - Common Stock - Currency: EUR

70.88  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to LEG. LEG was compared to 69 industry peers in the Real Estate Management & Development industry. While LEG is still in line with the averages on profitability rating, there are concerns on its financial health. LEG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year LEG was profitable.
In the past year LEG had a positive cash flow from operations.
LEG had positive earnings in 4 of the past 5 years.
In the past 5 years LEG always reported a positive cash flow from operatings.
LEG.DE Yearly Net Income VS EBIT VS OCF VS FCFLEG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B

1.2 Ratios

LEG has a Return On Assets of -2.98%. This is comparable to the rest of the industry: LEG outperforms 48.00% of its industry peers.
With a Return On Equity value of -8.03%, LEG perfoms like the industry average, outperforming 45.33% of the companies in the same industry.
LEG has a Return On Invested Capital of 1.50%. This is comparable to the rest of the industry: LEG outperforms 60.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LEG is below the industry average of 4.12%.
The 3 year average ROIC (1.33%) for LEG is below the current ROIC(1.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.98%
ROE -8.03%
ROIC 1.5%
ROA(3y)0.44%
ROA(5y)3.31%
ROE(3y)0.28%
ROE(5y)6.63%
ROIC(3y)1.33%
ROIC(5y)1.4%
LEG.DE Yearly ROA, ROE, ROICLEG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

With a decent Operating Margin value of 44.13%, LEG is doing good in the industry, outperforming 77.33% of the companies in the same industry.
LEG's Operating Margin has declined in the last couple of years.
LEG has a Gross Margin of 47.60%. This is comparable to the rest of the industry: LEG outperforms 57.33% of its industry peers.
In the last couple of years the Gross Margin of LEG has declined.
Industry RankSector Rank
OM 44.13%
PM (TTM) N/A
GM 47.6%
OM growth 3Y-3.91%
OM growth 5Y-2.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.37%
GM growth 5Y-3.02%
LEG.DE Yearly Profit, Operating, Gross MarginsLEG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LEG is destroying value.
LEG has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for LEG has been increased compared to 5 years ago.
Compared to 1 year ago, LEG has a worse debt to assets ratio.
LEG.DE Yearly Shares OutstandingLEG.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
LEG.DE Yearly Total Debt VS Total AssetsLEG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

LEG has an Altman-Z score of 0.76. This is a bad value and indicates that LEG is not financially healthy and even has some risk of bankruptcy.
LEG has a Altman-Z score (0.76) which is in line with its industry peers.
LEG has a debt to FCF ratio of 23.80. This is a negative value and a sign of low solvency as LEG would need 23.80 years to pay back of all of its debts.
LEG has a Debt to FCF ratio of 23.80. This is in the better half of the industry: LEG outperforms 69.33% of its industry peers.
A Debt/Equity ratio of 1.09 is on the high side and indicates that LEG has dependencies on debt financing.
LEG has a Debt to Equity ratio (1.09) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF 23.8
Altman-Z 0.76
ROIC/WACC0.5
WACC3.01%
LEG.DE Yearly LT Debt VS Equity VS FCFLEG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.3 Liquidity

LEG has a Current Ratio of 0.48. This is a bad value and indicates that LEG is not financially healthy enough and could expect problems in meeting its short term obligations.
LEG has a worse Current ratio (0.48) than 66.67% of its industry peers.
LEG has a Quick Ratio of 0.48. This is a bad value and indicates that LEG is not financially healthy enough and could expect problems in meeting its short term obligations.
LEG's Quick ratio of 0.47 is in line compared to the rest of the industry. LEG outperforms 42.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.47
LEG.DE Yearly Current Assets VS Current LiabilitesLEG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.55% over the past year.
LEG shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.59% yearly.
LEG shows a small growth in Revenue. In the last year, the Revenue has grown by 3.41%.
Measured over the past years, LEG shows a quite strong growth in Revenue. The Revenue has been growing by 10.10% on average per year.
EPS 1Y (TTM)52.55%
EPS 3Y-4.23%
EPS 5Y5.59%
EPS Q2Q%-23.36%
Revenue 1Y (TTM)3.41%
Revenue growth 3Y12.97%
Revenue growth 5Y10.1%
Sales Q2Q%3.2%

3.2 Future

Based on estimates for the next years, LEG will show a small growth in Earnings Per Share. The EPS will grow by 3.28% on average per year.
Based on estimates for the next years, LEG will show a small growth in Revenue. The Revenue will grow by 1.48% on average per year.
EPS Next Y6.14%
EPS Next 2Y3.8%
EPS Next 3Y3.28%
EPS Next 5YN/A
Revenue Next Year-4.93%
Revenue Next 2Y0.78%
Revenue Next 3Y1.48%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LEG.DE Yearly Revenue VS EstimatesLEG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
LEG.DE Yearly EPS VS EstimatesLEG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.80 indicates a correct valuation of LEG.
Based on the Price/Earnings ratio, LEG is valued a bit cheaper than the industry average as 78.67% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of LEG to the average of the S&P500 Index (29.35), we can say LEG is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 11.68, the valuation of LEG can be described as reasonable.
Based on the Price/Forward Earnings ratio, LEG is valued a bit cheaper than the industry average as 76.00% of the companies are valued more expensively.
LEG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.8
Fwd PE 11.68
LEG.DE Price Earnings VS Forward Price EarningsLEG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LEG is valued a bit cheaper than 70.67% of the companies in the same industry.
74.67% of the companies in the same industry are more expensive than LEG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.82
EV/EBITDA 25.48
LEG.DE Per share dataLEG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LEG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.41
PEG (5Y)2.65
EPS Next 2Y3.8%
EPS Next 3Y3.28%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.46%, LEG has a reasonable but not impressive dividend return.
LEG's Dividend Yield is a higher than the industry average which is at 7.29.
LEG's Dividend Yield is a higher than the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 3.46%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LEG.DE Yearly Dividends per shareLEG.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 2025 2 4 6

5.3 Sustainability

LEG has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-26.07%
EPS Next 2Y3.8%
EPS Next 3Y3.28%
LEG.DE Yearly Income VS Free CF VS DividendLEG.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B

LEG IMMOBILIEN SE

FRA:LEG (3/7/2025, 7:00:00 PM)

70.88

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)03-10 2025-03-10/amc
Inst Owners64.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.28B
Analysts77.5
Price Target101.19 (42.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.46%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-26.07%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.8%
Min EPS beat(2)-32.58%
Max EPS beat(2)-9.03%
EPS beat(4)1
Avg EPS beat(4)-10.15%
Min EPS beat(4)-32.58%
Max EPS beat(4)30.12%
EPS beat(8)1
Avg EPS beat(8)-29.9%
EPS beat(12)2
Avg EPS beat(12)-49.29%
EPS beat(16)3
Avg EPS beat(16)-31.64%
Revenue beat(2)1
Avg Revenue beat(2)16.12%
Min Revenue beat(2)-5.73%
Max Revenue beat(2)37.97%
Revenue beat(4)2
Avg Revenue beat(4)16.94%
Min Revenue beat(4)-7.26%
Max Revenue beat(4)42.79%
Revenue beat(8)4
Avg Revenue beat(8)11.64%
Revenue beat(12)8
Avg Revenue beat(12)21.27%
Revenue beat(16)12
Avg Revenue beat(16)20.24%
PT rev (1m)0.49%
PT rev (3m)1.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.9%
EPS NY rev (1m)0.2%
EPS NY rev (3m)1.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-3.81%
Valuation
Industry RankSector Rank
PE 14.8
Fwd PE 11.68
P/S 4.17
P/FCF 12.82
P/OCF 12.34
P/B 0.72
P/tB 0.72
EV/EBITDA 25.48
EPS(TTM)4.79
EY6.76%
EPS(NY)6.07
Fwd EY8.56%
FCF(TTM)5.53
FCFY7.8%
OCF(TTM)5.74
OCFY8.1%
SpS17
BVpS98.21
TBVpS98.16
PEG (NY)2.41
PEG (5Y)2.65
Profitability
Industry RankSector Rank
ROA -2.98%
ROE -8.03%
ROCE 3.21%
ROIC 1.5%
ROICexc 1.54%
ROICexgc 1.54%
OM 44.13%
PM (TTM) N/A
GM 47.6%
FCFM 32.53%
ROA(3y)0.44%
ROA(5y)3.31%
ROE(3y)0.28%
ROE(5y)6.63%
ROIC(3y)1.33%
ROIC(5y)1.4%
ROICexc(3y)1.36%
ROICexc(5y)1.43%
ROICexgc(3y)1.37%
ROICexgc(5y)1.44%
ROCE(3y)2.84%
ROCE(5y)2.99%
ROICexcg growth 3Y-0.67%
ROICexcg growth 5Y-4.46%
ROICexc growth 3Y-0.44%
ROICexc growth 5Y-4.3%
OM growth 3Y-3.91%
OM growth 5Y-2.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.37%
GM growth 5Y-3.02%
F-Score6
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF 23.8
Debt/EBITDA 13.89
Cap/Depr 105.96%
Cap/Sales 1.26%
Interest Coverage 3.55
Cash Conversion 74.57%
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.47
Altman-Z 0.76
F-Score6
WACC3.01%
ROIC/WACC0.5
Cap/Depr(3y)59.11%
Cap/Depr(5y)51.14%
Cap/Sales(3y)3.07%
Cap/Sales(5y)2.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.55%
EPS 3Y-4.23%
EPS 5Y5.59%
EPS Q2Q%-23.36%
EPS Next Y6.14%
EPS Next 2Y3.8%
EPS Next 3Y3.28%
EPS Next 5YN/A
Revenue 1Y (TTM)3.41%
Revenue growth 3Y12.97%
Revenue growth 5Y10.1%
Sales Q2Q%3.2%
Revenue Next Year-4.93%
Revenue Next 2Y0.78%
Revenue Next 3Y1.48%
Revenue Next 5YN/A
EBIT growth 1Y-2.43%
EBIT growth 3Y8.54%
EBIT growth 5Y7.84%
EBIT Next Year60.22%
EBIT Next 3Y20.31%
EBIT Next 5YN/A
FCF growth 1Y46.24%
FCF growth 3Y11.67%
FCF growth 5Y8.96%
OCF growth 1Y20.37%
OCF growth 3Y11.16%
OCF growth 5Y9.19%